000			01404 a2200397 4500
005			20250513193542.0
264		0	_c19991104
008			199911s 0 0 eng d
022			_a1524-4539
024	7		_a10.1161/01.cir.100.15.1586 _2doi
040			_aNLM _beng _cNLM
100	1		_aArmstrong, P W
245	0	0	_aPursuing progress in acute coronary syndromes. _h[electronic resource]
260			_bCirculation _cOct 1999
300			_a1586-9 p. _bdigital
500			_aPublication Type: Comment; Editorial
650	0	4	_aAcute Disease
650	0	4	_aAngina, Unstable _xdrug therapy
650	0	4	_aAnticoagulants _xadministration & dosage
650	0	4	_aClinical Trials as Topic
650	0	4	_aCoronary Disease _xdrug therapy
650	0	4	_aEnoxaparin _xadministration & dosage
650	0	4	_aFibrinolytic Agents _xadministration & dosage
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHeparin, Low-Molecular-Weight _xtherapeutic use
650	0	4	_aHospitalization
650	0	4	_aHumans
650	0	4	_aInjections, Subcutaneous
650	0	4	_aMeta-Analysis as Topic
650	0	4	_aMyocardial Infarction _xprevention & control
650	0	4	_aRecurrence
650	0	4	_aThrombolytic Therapy
650	0	4	_aTreatment Outcome
773	0		_tCirculation _gvol. 100 _gno. 15 _gp. 1586-9
856	4	0	_uhttps://doi.org/10.1161/01.cir.100.15.1586 _zAvailable from publisher's website
999			_c10474775 _d10474775